Helicos Raises New Funding
The existing investors making the purchase were Atlas Ventures, Flagship Ventures, Highland Capital Partners and Versant Ventures, which own 22%, 22%, 22% and 21% of the company’s outstanding shares respectively.
Cambridge, MA 9/16/09—Helicos Biosciences has raised approximately $9.4 million through a private placement of common stock and warrants. Purchasers include four existing investors, as well Ron Lowy, Helicos’s CEO, a new investor. In early September, the company announced it is considering strategic alternatives (see IBO 9/15/09).
< Previous Article | Next Article >